A "TNM" classification system for cancer pain: the Edmonton Classification System for Cancer Pain (ECS-CP).

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 18320239)

Published in Support Care Cancer on March 04, 2008

Authors

Robin L Fainsinger1, Cheryl L Nekolaichuk

Author Affiliations

1: Division of Palliative Care Medicine, Department of Oncology, University of Alberta, Edmonton, AB, Canada. Robin.Fainsinger@capitalhealth.ca

Articles citing this

A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic. Support Care Cancer (2014) 1.97

The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med (2010) 1.57

Pattern of palliative care, pain management and referral trends in patients receiving radiotherapy at a tertiary cancer center. Indian J Palliat Care (2009) 1.02

A personalized approach to assessing and managing pain in patients with cancer. J Clin Oncol (2014) 0.99

Improving access to specialist multidisciplinary palliative care consultation for rural cancer patients by videoconferencing: report of a pilot project. Support Care Cancer (2012) 0.95

Prevalence and correlates of pain in the Canadian National Palliative Care Survey. Pain Res Manag (2009) 0.94

Pharmacological options for the management of refractory cancer pain-what is the evidence? Support Care Cancer (2015) 0.93

A technical solution to improving palliative and hospice care. Support Care Cancer (2011) 0.90

Methadone initiation and rotation in the outpatient setting for patients with cancer pain. Cancer (2010) 0.88

A successful palliative care intervention for cancer pain refractory to intrathecal analgesia. J Pain Symptom Manage (2012) 0.82

Interviews with patients with advanced cancer--another step towards an international cancer pain classification system. Support Care Cancer (2012) 0.76

Reality of evidence-based practice in palliative care. Cancer Biol Med (2015) 0.76

The Association Between Activity Limitation Stages and Admission to Facilities Providing Long-term Care Among Older Medicare Beneficiaries. Am J Phys Med Rehabil (2016) 0.75

James Logan Prize Essay. The challenges of cancer pain assessment. Ulster Med J (2015) 0.75

Cancer pain--progress and ongoing issues in the United States. Pain Res Manag (2009) 0.75

Cancer pain--progress and ongoing issues in Canada. Pain Res Manag (2009) 0.75

Cancer pain--progress and ongoing issues in Europe. Pain Res Manag (2009) 0.75

Assessing the prognostic features of a pain classification system in advanced cancer patients. Support Care Cancer (2017) 0.75

Articles cited by this

Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain (1988) 3.06

Management of cancer pain. Lancet (1999) 2.76

Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain (1995) 2.69

Breakthrough pain: characteristics and impact in patients with cancer pain. Pain (1999) 2.53

Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage (1995) 2.51

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain (1990) 2.37

Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia. Lancet (1992) 2.34

A validation study of the WHO method for cancer pain relief. Cancer (1987) 2.32

Pharmacologic treatment of cancer pain. N Engl J Med (1996) 2.24

An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain (1999) 2.09

Opioid use in advanced malignant disease: why do different centers use vastly different doses? A plea for standardized reporting. J Pain Symptom Manage (1995) 2.00

A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage (2005) 1.86

Cancer pain and psychosocial factors: a critical review of the literature. J Pain Symptom Manage (2002) 1.56

Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer (1996) 1.31

The Edmonton staging system for cancer pain: preliminary report. Pain (1989) 1.21

A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage (1995) 1.18

A validation study of a pain classification system for advanced cancer patients using content experts: the Edmonton Classification System for Cancer Pain. Palliat Med (2005) 1.18

Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain (2003) 1.11

Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain (1999) 1.08

The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage (1995) 1.08

A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group. J Clin Oncol (1996) 1.00

Managing addiction in advanced cancer patients: why bother? J Pain Symptom Manage (2000) 0.99

Severe opioid toxicity and somatization of psychosocial distress in a cancer patient with a background of chemical dependence. J Pain Symptom Manage (1997) 0.98

Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosis. Oncology (Williston Park) (1998) 0.92

Narcotics in the elderly. Med Clin North Am (1982) 0.89

Should the rate of opioid dose escalation be included as a feature in a cancer pain classification system? J Pain Symptom Manage (2007) 0.87

Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain (1995) 0.86

Factors influencing the opioid response in advanced cancer patients with pain followed at home: the effects of age and gender. Support Care Cancer (2000) 0.86

An integrated psychosocial-spiritual model for cancer pain management. Cancer Pract (2002) 0.86

A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain. J Pain Symptom Manage (1997) 0.85

Development of a cancer pain prognostic scale. J Pain Symptom Manage (2002) 0.85

The clinical classification of malignant tumours: the TNM system. Can Med Assoc J (1971) 0.84

Investigation of an opioid response categorization in advanced cancer patients. J Pain Symptom Manage (1999) 0.82

Cancer pain at the end of life: a biopsychosocial perspective. Pain (2002) 0.82

Clinicopathologic correlates of common cancer pain syndromes. Hematol Oncol Clin North Am (1996) 0.80

The role of opioid receptor density in morphine tolerance. J Pharmacol Exp Ther (1991) 0.76

Pain analysis in prediction of treatment outcome. Acta Anaesthesiol Scand Suppl (1998) 0.75

Opioids, confusion and opioid rotation. Palliat Med (1998) 0.75

Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation. J Clin Oncol (1995) 0.75

Management of cancer pain: adults. Agency for Health Care Policy and Research. Am J Hosp Pharm (1994) 0.75